Bouvel Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$608K	Buy	43,815 +1,297	+3%	+$20.7K	0.18%	72
2025 Q4	$690K	Sell	42,518 -360	-0.8%	-$5.88K	0.2%	75
2025 Q3	$641K	Buy	42,878 +904	+2%	+$11K	0.2%	75
2025 Q2	$489K	Sell	41,974 -1,908	-4%	-$17.3K	0.17%	72
2025 Q1	$225K	Buy	43,882 +77	+0.2%	+$592	0.08%	77
2024 Q4	$263K	Sell	43,805 -77	-0.2%	-$425	0.09%	76
2024 Q3	$225K	Sell	43,882 -1,998	-4%	-$8.71K	0.08%	77
2024 Q2	$166K	Sell	45,880 -150	-0.3%	-$476	0.06%	77
2024 Q1	$148K	Buy	46,030 +830	+2%	+$3.21K	0.06%	75
2023 Q4	$221K	Buy	45,200 +1,001	+2%	+$4.57K	0.1%	77
2023 Q3	$241K	Buy	44,199 +376	+0.9%	+$2.49K	0.13%	77
2023 Q2	$294K	Buy	43,823 +1,391	+3%	+$10.3K	0.16%	71
2023 Q1	$375K	Buy	42,432 +1,240	+3%	+$10.9K	0.22%	68
2022 Q4	$315K	Buy	41,192 +1,534	+4%	+$11.9K	0.2%	66
2022 Q3	$282K	Buy	39,658 +25,158	+174%	+$237K	0.19%	66
2022 Q2	$117K	Buy	14,500 +113	+0.8%	+$994	0.09%	66
2022 Q1	$200K	Buy	14,387 +90	+0.6%	+$1.42K	0.12%	65
2021 Q4	$401K	Sell	14,297 -173	-1%	-$5.3K	0.22%	64
2021 Q3	$492K	Sell	14,470 -241	-2%	-$8.72K	0.28%	64
2021 Q2	$601K	Buy	14,711 +75	+0.5%	+$2.92K	0.34%	62
2021 Q1	$589K	Sell	14,636 -47	-0.3%	-$2.54K	0.38%	59
2020 Q4	$868K	Buy	+14,683	New	+$757K	0.62%	57